Fig. 4
From: Immune modulating nanoparticles for the treatment of ocular diseases
Model diagram of the inflammatory mechanism of ocular surface disease and the anti-inflammatory mechanism of nanoparticles. (A) Inflammatory signaling pathways involved in allergic conjunctivitis and ametropia induced by allergic conjunctivitis. (B) Major components of the immune response involved in acute DED. Copyright 2017, Royal Society of Chemistry. Reproduced under the terms of the CC-BY 4.0 license [73]. Copyright 2018, The Authors. Published by Elsevier. Reproduced under the terms of the CC-BY 4.0 license [77]. Copyright 2020, The Authors. Published by Elsevier.